- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Complaint alleged AstraZeneca’s exhibition stand at a restaurant meeting was visible to the public. Panel found insufficient evidence…
A health board complained about a market research recruitment email offering a ‘finder’s fee’ for AF patient interviews.…
A Pulse ‘Advertisement Feature’ for Levemir wasn’t disguised promotion, but weight-loss messaging from an uncontrolled observational study was…
Roche’s NeoRecormon congress panel/brochure used a “24% dose reduction vs darbepoetin alfa” and Hb target messaging based on…
A PR agency working for Janssen-Cilag offered journalists £200 to attend a NICE appeal hearing. Janssen-Cilag said it…
A member of the public challenged a Lilly erectile dysfunction TV advert as illegal public promotion. PMCPA found…
PMCPA case AUTH/2895/11/16 (Director v Boehringer Ingelheim) concerning clinical trial disclosure for Giotrif. Outcome: No breach; matter was…
Complaint alleged a third-party email linked GSK-sponsored COPD therapy reviews to “client product/therapy priorities”. Panel and Appeal Board…
Novartis-funded third‑party “medical education” videos were ruled promotional for unlicensed inclisiran, lacked clear sponsorship disclosure and certification, and…
BMJ ad framed as an acquisition announcement for Dificlir was ruled promotional. It lacked prescribing information and an…
One real case. One key lesson. Every week — free.